PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Many endocrine patients, providers want to continue telehealth after pandemic

Three in four patients say telehealth quality of care is similar to in-person visits

2021-03-20
(Press-News.org) WASHINGTON--Two-thirds of patients with chronic endocrine health problems who need close monitoring say they would like to continue with telemedicine follow-up visits after the COVID-19 pandemic ends, according to a survey that will be presented virtually at ENDO 2021, the Endocrine Society's annual meeting. Three-quarters of providers also said they want to continue with telehealth after the pandemic.

"Endocrinology clinics have significant number of patients who need long-term close follow-up for medication adjustments, symptom checks and counseling," said lead researcher Maryam Nemati, M.D., of San Joaquin General Hospital in French Camp, Calif. "Our survey found most patients felt that quality of telehealth visits both via video and phone were like in-person visits, and telemedicine is less expensive and timesaving. However, our providers felt that phone visits lack a physical examination component and therefore preferred video visits to phone visits. Given these survey results, telemedicine--particularly video visits--can be incorporated as part of follow-up visits after the COVID crisis ends."

Nemati wanted to evaluate patient and provider satisfaction with telehealth visits, which were initiated in 2020 to decrease COVID-19 transmission. The survey included 109 patients who had a telehealth endocrinology visit via video or phone call from January 2020 to May 2020. They were asked about the benefits and limitations of telehealth visits compared with in-person visits. Providers were also surveyed, and the researchers analyzed the patient no-show rate for six weeks before and after telehealth visits were implemented.

Among the patients surveyed: 65% said they would like to continue with telemedicine after the pandemic 77% stated the quality of care with telemedicine, both video and phone visits, are almost the same as an in-person visit. 45% said they liked spending less time with a telehealth visit 54% said the duration of the visit itself was about the same 54% believed they spent less money with telemedicine 90% said all their questions and concerns were addressed 37% reported no connectivity issues 25% reported technical difficulty Among providers: 75% wanted to continue with telehealth after the pandemic 50% reported patient satisfaction as a benefit of the telemedicine 25% reported that telemedicine saves time 46% of the providers mentioned lack of physical exam 40% mentioned connection issues as the limitation for video visit 60% believed lack of physical exam is the limitation of phone visit 75% believed the quality of care is similar in video and in person visits 87% of the providers believe the quality of care is better with in-person visits than phone visits The no-show rate decreased from 30% to 27% after the implementation of telehealth visits, the researchers found.

"Telehealth can be more efficient for both patients and providers, but there are challenges with connectivity issues, particularly for patients and community hospitals in rural areas like our hospital." Nemati said. "These issues need to be addressed, possibly through collaborations with local government and insurance companies."

INFORMATION:

Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world's oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.

The Society has more than 18,000 members, including scientists, physicians, educators, nurses and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at http://www.endocrine.org. Follow us on Twitter at @TheEndoSociety and @EndoMedia.



ELSE PRESS RELEASES FROM THIS DATE:

Combination thyroid hormone therapies treat hypothyroidism as well as levothyroxine

2021-03-20
WASHINGTON--Treatment of hypothyroidism, which results from an underactive thyroid gland, should be individualized and consideration should be given to alternatives to the first-line therapy, including desiccated thyroid extract and combination therapy to replace the body's two main thyroid hormones, thyroxine (T4) and triiodothyronine (T3). Results of their new randomized clinical study are being presented at ENDO 2021, the Endocrine Society's annual meeting. Combination therapy has been shown to be equally as effective as the standard treatment with levothyroxine alone, researchers say. "There are now proven good treatment options for the more than one in 10 patients with hypothyroidism who continue to experience symptoms of fatigue, mental fogginess, weight ...

Study finds oral testosterone therapy undecanoate is effective, with no liver toxicity

2021-03-20
WASHINGTON--An industry-supported study of an oral testosterone replacement therapy (TRT), testosterone undecanoate (TU, brand name Jatenzo) finds it is an effective, long-term treatment for men with low testosterone levels, with no evidence of liver toxicity. The findings are being presented virtually at ENDO 2021, the Endocrine Society's annual meeting. TST is currently available in multiple modes of administration, including implantable pellets, transdermal gels and intramuscular injections. "For many men with low testosterone levels, an oral option is preferred to avoid issues associated with other ...

Night owls with gestational diabetes may face higher risk of pregnancy complications

2021-03-20
WASHINGTON--Among women who develop diabetes during pregnancy, night owls have a higher risk of complications for mother and baby than early birds do, according to a study whose results will be presented at ENDO 2021, the Endocrine Society's annual meeting. Compared with other pregnant women with gestational diabetes, those with a preference for evening activity had three times higher the chance of having preeclampsia, which is pregnancy-induced high blood pressure, and four times the rate of their newborns being treated in a neonatal intensive care unit, the study investigators reported. These findings suggest a ...

First targeted therapy for children with achondroplasia shows persistent height gain

2021-03-20
WASHINGTON--Children with achondroplasia, the most common form of disproportionate short stature, grow taller with trends in improved body proportions after two years of daily vosoritide treatment, a new study analysis finds. Results of the industry-sponsored study will be presented at ENDO 2021, the Endocrine Society's annual meeting. "This is the first robust evidence of a precision therapy for achondroplasia," said the lead investigator, Ravi Savarirayan, M.D., Ph.D., a professor at Murdoch Children's Research Institute at Royal Children's Hospital in Parkville, Australia. Achondroplasia is a genetic bone growth ...

New treatment shows promise in preventing heart failure after heart attack

2021-03-20
WASHINGTON--A study in mice finds treatment with a molecule called MCB-613 repairs heart tissue after a severe heart attack, preventing damage that can lead to heart failure. The findings are being presented virtually at ENDO 2021, the Endocrine Society's annual meeting. "This is a remarkable discovery that may lead to effective and safe treatments to prevent the progression to heart failure after a heart attack," said lead researcher Lisa K. Mullany, Ph.D., of Baylor College of Medicine in Houston. Heart failure after a heart attack is the leading cause of death in humans, and currently there are no definitive therapies other than heart transplantation. Researchers had previously found that MCB-613 stimulates proteins called steroid receptor coactivators ...

Children with adrenal insufficiency are 10 times more likely to die from COVID-19

2021-03-20
WASHINGTON--Children with adrenal insufficiency--a condition in which the adrenal gland does not function properly--are at more than 10 times higher risk for COVID-19 complications and death compared with children with normal adrenal glands, according to a study presented virtually at ENDO 2021, the Endocrine Society's annual meeting. Adrenal insufficiency is a disorder that occurs when the adrenal glands, located just above the kidneys, don't make enough of the hormone cortisol. The primary form of adrenal insufficiency is also called Addison's disease. Known as the "stress ...

Children, teens with type 1 diabetes had better glucose control during COVID-19 lockdown

2021-03-20
WASHINGTON--Blood glucose levels improved among children and teens with type 1 diabetes during the first 12 weeks of COVID-19 lockdown in the United Kingdom, according to a study presented virtually at ENDO 2021, the Endocrine Society's annual meeting. "The findings demonstrate the difficulties faced by patients and families managing type 1 diabetes around school pressures, meals away from home, social life and peer pressure," said lead researcher Neil Lawrence, M.B.Ch.B., of Sheffield Children's Hospital NHS Foundation Trust in Sheffield, United Kingdom. "Children and families found it easier to manage this disease when they were ...

White button mushrooms could slow progression of prostate cancer

2021-03-20
WASHINGTON--The chemicals present in white button mushrooms may slow the progression of prostate cancer, according to a mouse study presented virtually at ENDO 2021, the Endocrine Society's annual meeting. "Androgens, a type of male sex hormone, promote the growth of prostate cancer cells by binding to and activating the androgen receptor, a protein that is expressed in prostate cells," said lead researcher Xiaoqiang Wang, M.D., Ph.D., M.B. (A.S.C.P.), of the Beckman Research Institute of City of Hope, a comprehensive cancer center in Duarte, Calif. "White button mushrooms appear to suppress the activity of the androgen receptor." City of Hope's Shiuan ...

Obesity raises type 2 diabetes risk in women with PCOS

2021-03-20
WASHINGTON--Women with obesity and polycystic ovarian syndrome (PCOS) are at increased risk of developing type 2 diabetes, according to a study presented virtually at ENDO 2021, the Endocrine Society's annual meeting. Normal-weight women with PCOS are not at increased risk, the researchers found. Women with PCOS had a more than three-fold increased risk of developing type 2 diabetes during their lifetime, the study found. This risk was evident only in women who met the criteria for overweight or obesity, but not in lean women. "We strongly suggest weight management in women with obesity and PCOS in an attempt to reduce this major risk of ...

Few patients at risk for common high blood pressure disorder receive screening

2021-03-20
WASHINGTON--Only 3% of patients at high risk for primary aldosteronism (PA), a common disorder that causes high blood pressure and can lead to heart and kidney complications, are screened for the condition, according to a study that will be presented virtually at ENDO 2021, the Endocrine Society's annual meeting. "The results of our study indicate that initiatives to encourage PA screening are crucial for preventing cardiovascular and kidney disease in many patients with hypertension," said lead researcher Seda Grigoryan, M.D., of Michigan State University in Lansing, Mich. PA is the most common form of secondary hypertension--high blood pressure caused by another disease. END ...

LAST 30 PRESS RELEASES:

Malnutrition in children rises when economy drops

New model enables the study of how protein complex influences mitochondrial function

Device study offers hopes for spinal cord injuries

How urea forms spontaneously

Mayo Clinic’s AI tool identifies 9 dementia types, including Alzheimer’s, with one scan

Gene therapy improves blood flow in the brain in patients with sickle cell disease

Building breast tissue in the lab to better understand lactation

How gut bacteria change after exposure to pesticides

Timepoint at which developing B-cells become cancerous impacts leukemia treatment

Roberto Morandotti wins prestigious IEEE Photonics Society Quantum Electronics Award 

New urine-based tumor DNA test may help personalize bladder cancer treatment

How a faulty transport protein in the brain can trigger severe epilepsy

Study reveals uneven land sinking across New Orleans, raising flood-risk concerns

Researchers uncover novel mechanism for regulating ribosome biogenesis during brain development

RNA codon expansion via programmable pseudouridine editing and decoding

Post-diagnosis emergency department presentation and demographic factors in malignant skin cancers

A new genetic tuner for embryo development

Insurance churn and the COVID-19 pandemic

Postpartum Medicaid use in birthing parents and access to financed care

Manufacturing chemicals via orthogonal strategy, making full use of waste plastic resources in real life

Study overturns long-held belief about shape of fish schools

Precision oncology Organ Chip platform accurately and actionably predicts chemotherapy responses of patients suffering from esophageal adenocarcinoma

Verify the therapeutic effect of effective components of lycium barbarum on hepatocellular carcinoma based on molecular docking

Early intervention changes trajectory for depressed preschoolers

HonorHealth Research Institute presents ‘monumental’ increase in survivability for patients suffering ultra-low blood pressure

Mitochondrial dynamics in breast cancer metastasis: From metabolic drivers to therapeutic targets

Removing out-of-pocket fee improves access to 3D mammography

Does reducing exposure to image and video content on messaging apps reduce the impact of misinformation? Yes and no

A global microbiome preservation effort enters its growth phase

New credit card-sized TB test could close the diagnostic gap in HIV hotspots

[Press-News.org] Many endocrine patients, providers want to continue telehealth after pandemic
Three in four patients say telehealth quality of care is similar to in-person visits